Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
- PMID: 15972864
- DOI: 10.1056/NEJMoa043938
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
Erratum in
- N Engl J Med. 2005 Aug 18;353(7):744
Abstract
Background: The risk of sudden death from cardiac causes is increased among survivors of acute myocardial infarction with reduced left ventricular systolic function. We assessed the risk and time course of sudden death in high-risk patients after myocardial infarction.
Methods: We studied 14,609 patients with left ventricular dysfunction, heart failure, or both after myocardial infarction to assess the incidence and timing of sudden unexpected death or cardiac arrest with resuscitation in relation to the left ventricular ejection fraction.
Results: Of 14,609 patients, 1067 (7 percent) had an event a median of 180 days after myocardial infarction: 903 died suddenly, and 164 were resuscitated after cardiac arrest. The risk was highest in the first 30 days after myocardial infarction--1.4 percent per month (95 percent confidence interval, 1.2 to 1.6 percent)--and decreased to 0.14 percent per month (95 percent confidence interval, 0.11 to 0.18 percent) after 2 years. Patients with a left ventricular ejection fraction of 30 percent or less were at highest risk in this early period (rate, 2.3 percent per month; 95 percent confidence interval, 1.8 to 2.8 percent). Nineteen percent of all sudden deaths or episodes of cardiac arrest with resuscitation occurred within the first 30 days after myocardial infarction, and 83 percent of all patients who died suddenly did so in the first 30 days after hospital discharge. Each decrease of 5 percentage points in the left ventricular ejection fraction was associated with a 21 percent adjusted increase in the risk of sudden death or cardiac arrest with resuscitation in the first 30 days.
Conclusions: The risk of sudden death is highest in the first 30 days after myocardial infarction among patients with left ventricular dysfunction, heart failure, or both. Thus, earlier implementation of strategies for preventing sudden death may be warranted in selected patients.
Copyright 2005 Massachusetts Medical Society.
Comment in
-
Sudden death after myocardial infarction--who needs prophylaxis, and when?N Engl J Med. 2005 Jun 23;352(25):2638-40. doi: 10.1056/NEJMe058085. N Engl J Med. 2005. PMID: 15972871 No abstract available.
-
Sudden death in patients with myocardial infarction.N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. doi: 10.1056/NEJMc051992. N Engl J Med. 2005. PMID: 16177257 No abstract available.
-
Sudden death in patients with myocardial infarction.N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. N Engl J Med. 2005. PMID: 16180269 No abstract available.
-
Sudden death in patients with myocardial infarction.N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. N Engl J Med. 2005. PMID: 16180270 No abstract available.
-
Sudden death in patients with myocardial infarction.N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. N Engl J Med. 2005. PMID: 16180271 No abstract available.
Similar articles
-
Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.Med Sci Monit. 2009 Jun;15(6):PH40-8. Med Sci Monit. 2009. PMID: 19478711
-
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.N Engl J Med. 1995 Dec 21;333(25):1670-6. doi: 10.1056/NEJM199512213332503. N Engl J Med. 1995. PMID: 7477219 Clinical Trial.
-
Ventricular dysfunction and the risk of stroke after myocardial infarction.N Engl J Med. 1997 Jan 23;336(4):251-7. doi: 10.1056/NEJM199701233360403. N Engl J Med. 1997. PMID: 8995087
-
[Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].Ital Heart J. 2005 Nov;6 Suppl 7:14S-23S. Ital Heart J. 2005. PMID: 16485513 Review. Italian.
-
Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.Circulation. 2007 May 8;115(18):2451-7. doi: 10.1161/CIRCULATIONAHA.106.683235. Circulation. 2007. PMID: 17485594 Review. No abstract available.
Cited by
-
Efficacy of Colchicine for Prevention of Stroke and Adverse Cardiovascular Events: A Meta-analysis of 16 Randomized Controlled Trials.Am J Cardiovasc Drugs. 2024 Oct 26. doi: 10.1007/s40256-024-00689-7. Online ahead of print. Am J Cardiovasc Drugs. 2024. PMID: 39460903
-
Psychological distress and arrhythmia: risk prediction and potential modifiers.Prog Cardiovasc Dis. 2013 May-Jun;55(6):582-9. doi: 10.1016/j.pcad.2013.03.001. Epub 2013 Apr 6. Prog Cardiovasc Dis. 2013. PMID: 23621968 Free PMC article. Review.
-
Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients.J Thromb Thrombolysis. 2022 Nov;54(4):569-578. doi: 10.1007/s11239-022-02704-7. Epub 2022 Sep 12. J Thromb Thrombolysis. 2022. PMID: 36094686
-
Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias.Nat Commun. 2015 Feb 2;6:6235. doi: 10.1038/ncomms7235. Nat Commun. 2015. PMID: 25639594 Free PMC article.
-
Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure.Curr Heart Fail Rep. 2012 Dec;9(4):267-76. doi: 10.1007/s11897-012-0107-7. Curr Heart Fail Rep. 2012. PMID: 22864856 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical